Ben Adams is an Author and Speaker at Field Sim. With a deep expertise in the life safety industry and a focus on healthcare technology, he explores themes such as medical equipment innovations, digital health, and consumer health. His insights have been featured in notable publications including BuzzFeed, The Telegraph, and Fierce Pharma.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Ben Adams primarily covers the health and pharmaceutical industries, focusing on corporate rebranding, drug advertising spending, regulatory petitions, and industry events. He also reports on healthcare-related initiatives and celebrity endorsements.
Given his focus on press releases and private sector announcements in the health and pharmaceutical industries, Ben is likely to be receptive to pitches that offer exclusive insights into major corporate developments within the sector. This could include new product launches or significant organizational changes within prominent companies.
Furthermore, given his coverage of regulatory petitions related to misleading promotions in the pharmaceutical industry, he may be interested in commentary from experts who can provide insight into legal or ethical issues surrounding healthcare marketing practices.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Belgian biopharma UCB is seeking to boost awareness of what epilepsy looks like to patients, literally, with a new campaign using art to tell their stories.
By: Ben Adams
Hot on the heels of the approval for AstraZeneca's breast cancer drug Etcamah, Guardant Health has been given the green light for its companion diagnostic.
By: Ben Adams
The recent cyberattack on Boston Scientific is looking more serious than the medtech major first thought, with the company predicting a possible hit to its third-quarter and full-year results.
Medtech and testing giant Labcorp has bought out MLM Medical Labs to help grow its geographic footprint for laboratory services.
The same psychology that makes you comfortable driving 70 mph in a 60 mph zone can make fire alarm shortcuts feel reasonable. They aren't.
GE HealthCare is said to be on the cusp of buying out radiopharmaceutical developer Sofie Biosciences, according to a report by the Financial Times.
As Novo Nordisk continues its epic battle with Eli Lilly for market share in the increasingly competitive obesity and diabetes space, Novo is launching a major rebranding of its business, its logo and its name.
By: Ben Adams
Johnson & Johnson is nearing a $20 billion deal to sell off its unwanted hips-and-knees business DePuy Synthes to private equity firm Apollo Equity Management.
By: Ben Adams
GSK is consolidating two of its influenza vaccine manufacturing sites into one, leaving hundreds of jobs at risk.
By: Ben Adams
Healthcare marketing and comms agency, Deerfield Group, is creating a new model for growth while making a series of appointments and promotions to help bolster its plans.
